BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 24829204)

  • 1. KLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of β-thalassemia.
    Liu D; Zhang X; Yu L; Cai R; Ma X; Zheng C; Zhou Y; Liu Q; Wei X; Lin L; Yan T; Huang J; Mohandas N; An X; Xu X
    Blood; 2014 Jul; 124(5):803-11. PubMed ID: 24829204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation of Krüppel-like factor 1 (KLF1) and fetal hemoglobin (HbF) levels in β
    Khamphikham P; Sripichai O; Munkongdee T; Fucharoen S; Tongsima S; Smith DR
    Int J Hematol; 2018 Mar; 107(3):297-310. PubMed ID: 29067594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mutation in the erythroid transcription factor KLF1 is likely responsible for ameliorating β-thalassemia major.
    Fanis P; Kousiappa I; Phylactides M; Kyrri A; Hadjigavriel M; Christou S; Sitarou M; Kleanthous M
    Hum Mutat; 2019 Oct; 40(10):1768-1780. PubMed ID: 31115947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in HbA2 and HbF in alpha thalassemia carriers with KLF1 mutation.
    Satta S; Paglietti ME; Sollaino MC; Barella S; Moi P; Desogus MF; Demartis FR; Manunza L; Origa R
    Blood Cells Mol Dis; 2017 May; 64():30-32. PubMed ID: 28342932
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Tamaddoni A; Khabaz Astaneh S; Tabaripour R; Akhavan-Niaki H
    Hemoglobin; 2019 Jan; 43(1):12-17. PubMed ID: 30747024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the Novel KLF1 Gene Mutation Lead to a Delay in Fetal Hemoglobin Switch?
    Hariharan P; Gorivale M; Colah R; Ghosh K; Nadkarni A
    Ann Hum Genet; 2017 May; 81(3):125-128. PubMed ID: 28369821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in hematological parameters in α-thalassemia individuals co-inherited with erythroid Krüppel-like factor mutations.
    Yu LH; Liu D; Cai R; Shang X; Zhang XH; Ma XX; Yan SH; Fang P; Zheng CG; Wei XF; Liu YH; Zhou TB; Xu XM
    Clin Genet; 2015 Jul; 88(1):56-61. PubMed ID: 24930900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphic variations influencing fetal hemoglobin levels: association study in beta-thalassemia carriers and in normal individuals of Portuguese origin.
    Pereira C; Relvas L; Bento C; Abade A; Ribeiro ML; Manco L
    Blood Cells Mol Dis; 2015 Apr; 54(4):315-20. PubMed ID: 25842369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation screening of the Krüppel-like factor 1 gene using single-strand conformational polymorphism in a cohort of Iranian β-thalassemia patients.
    Zaker-Kandjani B; Namdar-Aligoodarzi P; Azarkeivan A; Najmabadi H; Banan M
    Hemoglobin; 2015; 39(1):24-9. PubMed ID: 25583416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new Krüppel-like factor 1 mutation (c.947G > A or p.C316Y) in humans causes β-thalassemia minor.
    Nitta T; Kawano F; Yamashiro Y; Takagi F; Murata T; Tanaka T; Ferania M; Adhiyanto C; Hattori Y
    Hemoglobin; 2015; 39(2):121-6. PubMed ID: 25690802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound heterozygosity for KLF1 mutations is associated with microcytic hypochromic anemia and increased fetal hemoglobin.
    Huang J; Zhang X; Liu D; Wei X; Shang X; Xiong F; Yu L; Yin X; Xu X
    Eur J Hum Genet; 2015 Oct; 23(10):1341-8. PubMed ID: 25585695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation Screening of the Krüppel-like Factor 1 Gene in Individuals With Increased Fetal Hemoglobin Referred for Hemoglobinopathy Investigation in South of Iran.
    Hamid M; Ershadi Oskouei S; Shariati G; Babaei E; Galehdari H; Saberi A; Sedaghat A
    J Pediatr Hematol Oncol; 2018 Apr; 40(3):192-195. PubMed ID: 29420372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KLF1 gene mutations in Chinese adults with increased fetal hemoglobin.
    Wang T; He Y; Zhou JY; Xie XM; Li J; Li R; Liao C; Li DZ
    Hemoglobin; 2013; 37(5):501-6. PubMed ID: 23806141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations on high HbF levels may be associated with KLF1 gene mutations.
    Aydin M; Rencuzogullari E; Bayram S; Sevgiler Y; Genc A
    Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):51-57. PubMed ID: 28886314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Functional Analysis of Known and New Mutations in the Transcription Factor KLF1 Linked with β-Thalassemia-like Phenotypes.
    Catapano R; Sessa R; Trombetti S; Cesaro E; Russo F; Izzo P; Makis A; Grosso M
    Biology (Basel); 2023 Mar; 12(4):. PubMed ID: 37106711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KFL1 Gene Variants in α-Thalassemia Individuals with Increased Fetal Hemoglobin in a Chinese Population.
    Jiang F; Qu YX; Chen GL; Li J; Zhou JY; Zuo LD; Liao C; Li DZ
    Hemoglobin; 2018 May; 42(3):161-165. PubMed ID: 30205725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic variants in members of the Krüppel-like factor gene family are associated with disease severity and hydroxyurea treatment efficacy in β-hemoglobinopathies patients.
    Stratopoulos A; Kolliopoulou A; Karamperis K; John A; Kydonopoulou K; Esftathiou G; Sgourou A; Kourakli A; Vlachaki E; Chalkia P; Theodoridou S; Papadakis MN; Gerou S; Symeonidis A; Katsila T; Ali BR; Papachatzopoulou A; Patrinos GP
    Pharmacogenomics; 2019 Jul; 20(11):791-801. PubMed ID: 31393228
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of association of G779A ZHX-2 gene variant with HbF levels in β-thalassemia major.
    Munshi A; Dadheech S; Jain S; Joseph J; Al-Hazzani A; Alshatwi AA; Sai Babu M; Rajeshwar K; Jyothy A
    Eur J Haematol; 2011 Jun; 86(6):502-6. PubMed ID: 21443521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KLF1: when less is more.
    Manwani D; Bieker JJ
    Blood; 2014 Jul; 124(5):672-3. PubMed ID: 25082863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KLF10 gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients.
    Borg J; Phylactides M; Bartsakoulia M; Tafrali C; Lederer C; Felice AE; Papachatzopoulou A; Kourakli A; Stavrou EF; Christou S; Hou J; Karkabouna S; Lappa-Manakou C; Ozgur Z; van Ijcken W; von Lindern M; Grosveld FG; Georgitsi M; Kleanthous M; Philipsen S; Patrinos GP
    Pharmacogenomics; 2012 Oct; 13(13):1487-500. PubMed ID: 23057549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.